CETRORELIX ACETATE

CETRORELIX ACETATE was reported 634 times

CETRORELIX ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PREMATURE OVULATION 41 0.5256
1 ASSISTED REPRODUCTIVE TECHNOLOGY 1 0.5000
2 PAROVARIAN CYST 1 0.1000
3 BLOOD LUTEINISING HORMONE INCREASED 17 0.0691
4 OVARIAN HYPERSTIMULATION SYNDROME 136 0.0583
5 VERTEBROBASILAR ARTERY DISSECTION 5 0.0568
6 OVARIAN TORSION 3 0.0361
7 PERITONEAL FLUID ANALYSIS ABNORMAL 3 0.0341
8 NONINFECTIVE OOPHORITIS 2 0.0299
9 BLOOD OESTROGEN INCREASED 15 0.0255
10 OVARIAN HAEMORRHAGE 6 0.0253
11 VACCINATION SITE MASS 1 0.0244
12 PROGESTERONE ABNORMAL 1 0.0222
13 MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE 3 0.0195
14 IMMINENT ABORTION 1 0.0182
15 HUMAN CHORIONIC GONADOTROPIN ABNORMAL 1 0.0172
16 FAILED IN VITRO FERTILISATION 1 0.0164
17 HETEROTOPIC PREGNANCY 1 0.0159
18 OVARIAN NECROSIS 1 0.0159
19 RETT SYNDROME 1 0.0156
20 OESTRADIOL ABNORMAL 1 0.0152
21 BORDERLINE OVARIAN TUMOUR 1 0.0149
22 ENDOTOXIC SHOCK 1 0.0145
23 PELVIC FLUID COLLECTION 10 0.0142
24 OVARIAN ENLARGEMENT 5 0.0131
25 INGUINAL HERNIA, OBSTRUCTIVE 1 0.0125
26 POLYNEUROPATHY IN MALIGNANT DISEASE 1 0.0122
27 CERVIX CERCLAGE PROCEDURE 1 0.0122
28 OVARIAN DISORDER 11 0.0117
29 UTERINE TENDERNESS 1 0.0116
30 HAEMOCONCENTRATION 2 0.0116
31 PROCEDURAL FAILURE 2 0.0112
32 ADNEXAL TORSION 3 0.0095
33 BIOCHEMICAL PREGNANCY 1 0.0093
34 URETERIC INJURY 1 0.0089
35 LABOUR COMPLICATION 2 0.0085
36 TWIN PREGNANCY 7 0.0083
37 TUBO-OVARIAN ABSCESS 2 0.0082
38 DYSACUSIS 1 0.0081
39 RESPIRATORY TRACT MALFORMATION 1 0.0075
40 DELAYED DELIVERY 1 0.0070
41 POSTMATURE BABY 1 0.0068
42 SHORTENED CERVIX 2 0.0068
43 PELVIC HAEMATOMA 3 0.0068
44 PERITONEAL HAEMORRHAGE 9 0.0065
45 PROGESTERONE DECREASED 2 0.0064
46 ENTEROBACTER PNEUMONIA 1 0.0064
47 PROLONGED PREGNANCY 1 0.0064
48 BLADDER INJURY 2 0.0063
49 MORPHOEA 3 0.0062
50 ABORTION THREATENED 3 0.0060
51 SUSPECTED PRODUCT QUALITY ISSUE 11 0.0060
52 ANAEMIA OF PREGNANCY 1 0.0058
53 SUBCHORIONIC HAEMATOMA 1 0.0057
54 BLOOD LUTEINISING HORMONE DECREASED 1 0.0056
55 MULTIPLE PREGNANCY 1 0.0056
56 IN VITRO FERTILISATION 1 0.0055
57 CERVIX HAEMORRHAGE UTERINE 1 0.0052
58 HEART VALVE CALCIFICATION 1 0.0050
59 ANOVULATORY CYCLE 1 0.0048
60 VACCINATION SITE ERYTHEMA 1 0.0046
61 FEMALE REPRODUCTIVE TRACT DISORDER 1 0.0046
62 CONGENITAL HEART VALVE DISORDER 1 0.0042
63 AMNIOTIC CAVITY INFECTION 3 0.0041
64 CERVICAL INCOMPETENCE 2 0.0039
65 EFFUSION 5 0.0037
66 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 2 0.0033
67 ECTOPIC PREGNANCY 10 0.0032
68 DRUG EXPOSURE BEFORE PREGNANCY 3 0.0030
69 VASCULAR STENOSIS 1 0.0029
70 THYROXINE INCREASED 2 0.0028
71 ARTERIAL THROMBOSIS 5 0.0026
72 RUPTURED ECTOPIC PREGNANCY 2 0.0026
73 PLACENTA PRAEVIA 2 0.0025
74 AMAUROSIS 2 0.0024
75 THREATENED LABOUR 1 0.0023
76 ALLERGY TEST POSITIVE 1 0.0022
77 PREMENSTRUAL SYNDROME 3 0.0022
78 NECROSIS ISCHAEMIC 1 0.0022
79 URINARY TRACT PAIN 1 0.0020
80 DRUG LEVEL DECREASED 20 0.0020
81 OVARIAN FAILURE 1 0.0019
82 ARRHYTHMIA SUPRAVENTRICULAR 2 0.0018
83 LYMPHOCYTE MORPHOLOGY ABNORMAL 1 0.0017
84 PROLONGED LABOUR 1 0.0016
85 HYDROPS FOETALIS 1 0.0016
86 TOXIC SHOCK SYNDROME 1 0.0016
87 ABORTION MISSED 2 0.0016
88 ADNEXA UTERI PAIN 2 0.0016
89 GESTATIONAL HYPERTENSION 2 0.0015
90 CYTOKINE STORM 1 0.0015
91 PRERENAL FAILURE 2 0.0014
92 FOETAL EXPOSURE TIMING UNSPECIFIED 1 0.0014
93 QRS AXIS ABNORMAL 1 0.0013
94 BREAST FEEDING 1 0.0013
95 GENERALISED TONIC-CLONIC SEIZURE 21 0.0013
96 PLACENTAL INSUFFICIENCY 1 0.0012
97 HEAT EXHAUSTION 1 0.0012
98 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
99 ABSCESS DRAINAGE 1 0.0012
100 HYPERLEUKOCYTOSIS 1 0.0011
101 PRODUCT RECONSTITUTION QUALITY ISSUE 1 0.0011
102 HUMAN CHORIONIC GONADOTROPIN INCREASED 1 0.0011
103 CONDUCTION DISORDER 2 0.0011
104 GESTATIONAL DIABETES 5 0.0010
105 CROSS SENSITIVITY REACTION 1 0.0010
106 MUCOSAL DISORDER 1 0.0010
107 UTERINE PAIN 1 0.0010
108 ABORTION SPONTANEOUS 39 0.0010
109 BREAST DISCOMFORT 1 0.0010
110 UTERINE CONTRACTIONS DURING PREGNANCY 1 0.0010
111 POSTICTAL STATE 1 0.0010
112 CYTOGENETIC ANALYSIS ABNORMAL 1 0.0010
113 ASCITES 28 0.0010
114 VASCULAR CALCIFICATION 1 0.0009
115 IMMEDIATE POST-INJECTION REACTION 1 0.0009
116 PREMATURE LABOUR 5 0.0009
117 MATERNAL EXPOSURE BEFORE PREGNANCY 6 0.0009
118 HAEMATOCRIT INCREASED 2 0.0009
119 INTRA-ABDOMINAL HAEMORRHAGE 2 0.0008
120 PREMATURE RUPTURE OF MEMBRANES 2 0.0008
121 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
122 BLADDER DISCOMFORT 1 0.0008
123 VAGINAL ODOUR 1 0.0008
124 TRISOMY 21 1 0.0008
125 IATROGENIC INJURY 1 0.0008
126 FOETAL DEATH 4 0.0008
127 ABDOMINAL OPERATION 1 0.0008
128 ABDOMINAL MASS 2 0.0007
129 IMMUNOGLOBULINS DECREASED 1 0.0007
130 INTENSIVE CARE 1 0.0007
131 HAEMORRHAGE IN PREGNANCY 1 0.0007
132 HAEMOTHORAX 2 0.0007
133 CAESAREAN SECTION 8 0.0007
134 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
135 INJECTION SITE PARAESTHESIA 1 0.0007
136 POLYCYSTIC OVARIES 1 0.0006
137 NEONATAL DISORDER 1 0.0006
138 LOW BIRTH WEIGHT BABY 5 0.0006
139 INTRA-UTERINE DEATH 1 0.0006
140 PITUITARY TUMOUR BENIGN 1 0.0006
141 RENAL CELL CARCINOMA 3 0.0006
142 GAZE PALSY 1 0.0006
143 JUGULAR VEIN THROMBOSIS 1 0.0006
144 UTERINE POLYP 1 0.0006
145 CEREBRAL VENOUS THROMBOSIS 1 0.0006
146 HYDROCEPHALUS 3 0.0006
147 HYPOMANIA 2 0.0005
148 PUPILLARY REFLEX IMPAIRED 1 0.0005
149 RETINOPATHY 2 0.0005
150 JAUNDICE NEONATAL 1 0.0005
151 PRODUCT STORAGE ISSUE 2 0.0005
152 PREGNANCY 10 0.0005
153 CAPILLARY LEAK SYNDROME 1 0.0005
154 GASTROINTESTINAL PERFORATION 2 0.0005
155 URINARY BLADDER HAEMORRHAGE 1 0.0005
156 BIPOLAR I DISORDER 1 0.0005
157 INJECTION SITE URTICARIA 11 0.0004
158 PELVIC PAIN 8 0.0004
159 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
160 HAEMANGIOMA 1 0.0004
161 ABORTION INDUCED 4 0.0004
162 PULMONARY INFARCTION 1 0.0004
163 DIABETES INSIPIDUS 1 0.0004
164 ABNORMAL UTERINE BLEEDING 1 0.0004
165 HEPATOSPLENOMEGALY 1 0.0004
166 ANAESTHETIC COMPLICATION 1 0.0004
167 BREAST SWELLING 1 0.0004
168 SKIN DISCOMFORT 1 0.0004
169 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
170 PLEURITIC PAIN 1 0.0004
171 NECROSIS 2 0.0004
172 LUNG CONSOLIDATION 1 0.0004
173 PRODUCT LEAKAGE 2 0.0004
174 OESOPHAGEAL STENOSIS 1 0.0004
175 POST PROCEDURAL HAEMORRHAGE 4 0.0003
176 DRUG EXPOSURE DURING PREGNANCY 11 0.0003
177 INJECTION SITE HYPERSENSITIVITY 1 0.0003
178 PNEUMONIA VIRAL 1 0.0003
179 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
180 MANIA 5 0.0003
181 OVARIAN CYST 3 0.0003
182 HEPATIC CYST 1 0.0003
183 INJECTION SITE RASH 9 0.0003
184 VIITH NERVE PARALYSIS 1 0.0003
185 ABDOMINAL DISTENSION 30 0.0003
186 CONJUNCTIVAL HYPERAEMIA 1 0.0003
187 HYPERACUSIS 1 0.0003
188 BREAST TENDERNESS 2 0.0003
189 MATERNAL DRUGS AFFECTING FOETUS 2 0.0003
190 PULMONARY HAEMORRHAGE 2 0.0003
191 VENOUS THROMBOSIS 1 0.0003
192 AFFECTIVE DISORDER 2 0.0003
193 EXPOSURE VIA BREAST MILK 1 0.0003
194 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
195 INJURY ASSOCIATED WITH DEVICE 5 0.0002
196 PERIPHERAL ISCHAEMIA 1 0.0002
197 LIVE BIRTH 2 0.0002
198 UTERINE HAEMORRHAGE 1 0.0002
199 FACIAL PARALYSIS 2 0.0002
200 TENSION HEADACHE 1 0.0002
201 VULVOVAGINAL DISCOMFORT 1 0.0002
202 INJECTION SITE PRURITUS 15 0.0002
203 GASTROINTESTINAL INFECTION 2 0.0002
204 PAPILLOEDEMA 1 0.0002
205 VASCULAR DEVICE INFECTION 1 0.0002
206 OPTIC NEURITIS 2 0.0002
207 URINE ABNORMALITY 1 0.0002
208 HAEMOGLOBIN INCREASED 1 0.0002
209 INJECTION SITE PAPULE 1 0.0002
210 ENDOMETRIOSIS 1 0.0002
211 TUMOUR MARKER INCREASED 1 0.0002
212 ENTEROCOCCAL INFECTION 1 0.0002
213 NEEDLE ISSUE 6 0.0002
214 PHARYNGEAL SWELLING 2 0.0002
215 SMALL FOR DATES BABY 1 0.0002
216 PROTEIN URINE PRESENT 1 0.0002
217 HYPOTONIA 2 0.0002
218 PREMATURE BABY 6 0.0002
219 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
220 KLEBSIELLA INFECTION 1 0.0002
221 PETECHIAE 2 0.0002
222 CATATONIA 1 0.0002
223 NYSTAGMUS 1 0.0002
224 INTESTINAL RESECTION 1 0.0002
225 NORMAL NEWBORN 1 0.0002
226 DEAFNESS UNILATERAL 1 0.0002
227 PLEURAL EFFUSION 11 0.0002
228 INTERMENSTRUAL BLEEDING 1 0.0002
229 HYPERVENTILATION 1 0.0002
230 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
231 INJECTION SITE VESICLES 1 0.0002
232 LARYNGEAL OEDEMA 1 0.0002
233 OLIGURIA 1 0.0002
234 SWELLING OF EYELID 1 0.0002
235 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
236 MYDRIASIS 2 0.0002
237 INCOHERENT 1 0.0002
238 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
239 PRODUCT PREPARATION ISSUE 1 0.0002
240 ANKYLOSING SPONDYLITIS 2 0.0002
241 MENINGITIS 1 0.0001
242 EYE MOVEMENT DISORDER 1 0.0001
243 NEPHROTIC SYNDROME 1 0.0001
244 SINUS TACHYCARDIA 2 0.0001
245 FEAR OF INJECTION 1 0.0001
246 VAGINAL HAEMORRHAGE 6 0.0001
247 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
248 ORAL DISORDER 1 0.0001
249 BLINDNESS TRANSIENT 1 0.0001
250 TRANSAMINASES INCREASED 3 0.0001
251 DRUG INTERACTION 21 0.0001
252 INJECTION SITE SWELLING 10 0.0001
253 PROCEDURAL COMPLICATION 1 0.0001
254 ATRIOVENTRICULAR BLOCK 1 0.0001
255 INJECTION SITE ERYTHEMA 16 0.0001
256 RENAL CYST 1 0.0001
257 PREMATURE DELIVERY 2 0.0001
258 BREAST CANCER STAGE II 1 0.0001
259 SYNCOPE 12 0.0001
260 ABDOMINAL PAIN LOWER 3 0.0001
261 INFUSION SITE ERYTHEMA 1 0.0001
262 METRORRHAGIA 2 0.0001
263 ANURIA 1 0.0001
264 PSYCHOLOGICAL TRAUMA 1 0.0001
265 SYRINGE ISSUE 2 0.0001
266 COLD SWEAT 2 0.0001
267 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
268 RESPIRATORY RATE INCREASED 1 0.0001
269 ABDOMINAL PAIN 26 0.0001
270 OVARIAN CANCER 1 0.0001
271 CHEST DISCOMFORT 11 0.0001
272 BACTERIAL INFECTION 2 0.0001
273 HYPONATRAEMIA 6 0.0001
274 SQUAMOUS CELL CARCINOMA 1 0.0001
275 ATELECTASIS 1 0.0001
276 POOR QUALITY DEVICE USED 1 0.0001
277 VAGINAL DISCHARGE 1 0.0001
278 DISCOMFORT 6 0.0001
279 PERITONITIS 2 0.0001
280 EXPOSURE DURING PREGNANCY 6 0.0001
281 UNEVALUABLE EVENT 7 0.0001
282 NERVE INJURY 1 0.0001
283 CHOLECYSTECTOMY 1 0.0001
284 SHOCK 2 0.0001
285 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
286 BLOOD IRON DECREASED 1 0.0001
287 URTICARIA 14 0.0001
288 PRESYNCOPE 2 0.0001
289 CONDITION AGGRAVATED 25 0.0001
290 INJECTION SITE EXTRAVASATION 1 0.0001
291 ABNORMAL WEIGHT GAIN 1 0.0001
292 GENERALISED OEDEMA 1 0.0001
293 HAIR COLOUR CHANGES 1 0.0001
294 INJECTION SITE DISCOLOURATION 1 0.0001
295 INJECTION SITE IRRITATION 1 0.0001
296 ANAPHYLACTIC SHOCK 2 0.0001
297 INJECTION SITE INDURATION 1 0.0001
298 DEEP VEIN THROMBOSIS 5 0.0001
299 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
300 IMMUNE SYSTEM DISORDER 1 0.0001
301 ADVERSE REACTION 1 0.0001
302 EYE HAEMORRHAGE 1 0.0001
303 HAIR TEXTURE ABNORMAL 1 0.0001
304 DEVICE BREAKAGE 3 0.0001
305 PULMONARY EMBOLISM 7 0.0001
306 TACHYPNOEA 1 0.0001
307 ANAPHYLACTIC REACTION 4 0.0001
308 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
309 SKIN REACTION 1 0.0001
310 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
311 HEPATOCELLULAR INJURY 1 0.0001
312 INTENTIONAL DOSE OMISSION 2 0.0001
313 PARAESTHESIA ORAL 1 0.0001
314 DEVICE LEAKAGE 3 0.0001
315 LIVER FUNCTION TEST ABNORMAL 2 0.0001
316 URINARY INCONTINENCE 2 0.0001
317 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
318 SKIN HAEMORRHAGE 1 0.0001
319 HYPERSENSITIVITY 12 0.0001
320 ACUTE MYELOID LEUKAEMIA 1 0.0001
321 SWELLING 6 0.0001
322 LOSS OF CONSCIOUSNESS 8 0.0001
323 VIRAL INFECTION 2 0.0001
324 LIP SWELLING 2 0.0001
325 TYPE 2 DIABETES MELLITUS 2 0.0001
326 SCAR 1 0.0001
327 DEVICE DEFECTIVE 1 0.0001
328 DELIRIUM 2 0.0001
329 MUSCULOSKELETAL PAIN 3 0.0001
330 DEVICE USE ISSUE 1 0.0001
331 ISCHAEMIC STROKE 1 0.0001
332 CRYING 2 0.0001
333 RESTLESS LEGS SYNDROME 1 0.0001
334 DYSURIA 2 0.0001
335 THINKING ABNORMAL 1 0.0001
336 BLOOD SODIUM DECREASED 1 0.0001
337 FOOT FRACTURE 1 0.0001
338 PRODUCT USE IN UNAPPROVED INDICATION 13 0.0001
339 PULMONARY FIBROSIS 1 0.0001
340 CHOKING 1 0.0001
341 HEART RATE INCREASED 5 0.0001
342 HAEMATOCRIT DECREASED 1 0.0001
343 INJECTION SITE HAEMORRHAGE 4 0.0001
344 CYTOKINE RELEASE SYNDROME 1 0.0000
345 PRODUCT PHYSICAL ISSUE 1 0.0000
346 PRODUCT PREPARATION ERROR 1 0.0000
347 INJECTION SITE WARMTH 1 0.0000
348 HAEMORRHAGE 5 0.0000
349 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
350 PRODUCT DISPENSING ERROR 1 0.0000
351 ANGIOEDEMA 2 0.0000
352 TACHYCARDIA 4 0.0000
353 PRODUCT AVAILABILITY ISSUE 1 0.0000
354 SKIN DISCOLOURATION 2 0.0000
355 PERICARDIAL EFFUSION 1 0.0000
356 SLEEP DISORDER 3 0.0000
357 HYPOGLYCAEMIA 2 0.0000
358 CEREBRAL INFARCTION 1 0.0000
359 DIPLOPIA 1 0.0000
360 DIZZINESS 19 0.0000
361 INJECTION SITE BRUISING 3 0.0000
362 BREAST CANCER FEMALE 1 0.0000
363 LIMB INJURY 1 0.0000
364 RASH 16 0.0000
365 RESPIRATORY DISTRESS 1 0.0000
366 PROCEDURAL PAIN 1 0.0000
367 HAEMOPTYSIS 1 0.0000
368 FLATULENCE 2 0.0000
369 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
370 RED BLOOD CELL COUNT DECREASED 1 0.0000
371 HYPERSOMNIA 1 0.0000
372 PALPITATIONS 4 0.0000
373 DRUG INEFFECTIVE 45 0.0000
374 CHILLS 4 0.0000
375 SURGERY 2 0.0000
376 VOMITING 16 0.0000
377 PRURITUS 13 0.0000
378 HEADACHE 21 0.0000
379 RESPIRATORY DISORDER 1 0.0000
380 BLOOD POTASSIUM DECREASED 1 0.0000
381 OFF LABEL USE 29 0.0000
382 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
383 EPILEPSY 1 0.0000
384 MUSCLE SPASMS 6 0.0000
385 DRUG ADMINISTRATION ERROR 1 0.0000
386 EMOTIONAL DISORDER 1 0.0000
387 LIMB DISCOMFORT 1 0.0000
388 SWOLLEN TONGUE 1 0.0000
389 MALAISE 14 0.0000
390 PARAESTHESIA 5 0.0000
391 CHOLELITHIASIS 1 0.0000
392 NAUSEA 24 0.0000
393 EXPIRED PRODUCT ADMINISTERED 1 0.0000
394 INJECTION SITE PAIN 9 0.0000
395 INJECTION SITE REACTION 2 0.0000
396 RASH MACULAR 1 0.0000
397 DEVICE MALFUNCTION 2 0.0000
398 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
399 C-REACTIVE PROTEIN INCREASED 1 0.0000
400 RESPIRATORY FAILURE 2 0.0000
401 ACCIDENTAL OVERDOSE 1 0.0000
402 INJECTION SITE MASS 1 0.0000
403 EYE SWELLING 1 0.0000
404 HEPATIC FUNCTION ABNORMAL 1 0.0000
405 DYSARTHRIA 1 0.0000
406 DYSPNOEA EXERTIONAL 1 0.0000
407 HOT FLUSH 2 0.0000
408 DYSPNOEA 15 0.0000
409 MUSCULAR WEAKNESS 3 0.0000
410 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
411 SEIZURE 3 0.0000
412 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
413 THROMBOSIS 2 0.0000
414 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
415 BLINDNESS 1 0.0000
416 NEUTROPHIL COUNT DECREASED 1 0.0000
417 INFLUENZA LIKE ILLNESS 2 0.0000
418 TREATMENT FAILURE 2 0.0000
419 ABDOMINAL DISCOMFORT 4 0.0000
420 CONSTIPATION 5 0.0000
421 DEVICE ISSUE 2 0.0000
422 INCORRECT DOSE ADMINISTERED 5 0.0000
423 SKIN IRRITATION 1 0.0000
424 TINNITUS 1 0.0000
425 HYPOKALAEMIA 1 0.0000
426 ARRHYTHMIA 1 0.0000
427 NEUROPATHY PERIPHERAL 2 0.0000
428 DISEASE RECURRENCE 1 0.0000
429 ANAEMIA 4 0.0000
430 RASH ERYTHEMATOUS 1 0.0000
431 GAIT DISTURBANCE 4 0.0000
432 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
433 CONTUSION 2 0.0000
434 ATRIAL FIBRILLATION 2 0.0000
435 HYPOTENSION 4 0.0000
436 SINUSITIS 2 0.0000
437 HAEMOGLOBIN DECREASED 2 0.0000
438 PERIPHERAL SWELLING 3 0.0000
439 ERYTHEMA 4 0.0000
440 INFLAMMATION 1 0.0000
441 DERMATITIS ATOPIC 1 0.0000
442 PANCREATITIS 1 0.0000
443 HYPERTENSION 4 0.0000
444 OVERDOSE 4 0.0000
445 RASH PRURITIC 1 0.0000
446 OEDEMA 1 0.0000
447 TREATMENT NONCOMPLIANCE 1 0.0000
448 ARTHROPATHY 1 0.0000
449 SEPSIS 2 0.0000
450 NECK PAIN 1 0.0000
451 OXYGEN SATURATION DECREASED 1 0.0000
452 EYE PAIN 1 0.0000
453 LETHARGY 1 0.0000
454 PRODUCT SUBSTITUTION ISSUE 1 0.0000
455 FEELING ABNORMAL 4 0.0000
456 IRRITABILITY 1 0.0000
457 NO ADVERSE EVENT 3 0.0000
458 THERAPEUTIC RESPONSE DECREASED 1 0.0000
459 VERTIGO 1 0.0000
460 FEELING HOT 1 0.0000
461 PRODUCT USE ISSUE 3 0.0000
462 DEVICE EXPULSION 1 0.0000
463 AMNESIA 1 0.0000
464 SWELLING FACE 1 0.0000
465 ALOPECIA 3 0.0000
466 RENAL FAILURE 2 0.0000
467 BLOOD PRESSURE DECREASED 1 0.0000
468 INSOMNIA 4 0.0000
469 SOMNOLENCE 3 0.0000
470 HEPATIC ENZYME INCREASED 1 0.0000
471 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
472 VISION BLURRED 2 0.0000
473 BURNING SENSATION 1 0.0000
474 FATIGUE 11 0.0000
475 THERAPY INTERRUPTED 1 0.0000
476 SKIN BURNING SENSATION 1 0.0000
477 MOBILITY DECREASED 1 0.0000
478 PRODUCT DOSE OMISSION ISSUE 4 0.0000
479 PAIN IN EXTREMITY 4 0.0000
480 HYPOAESTHESIA 2 0.0000
481 DIABETES MELLITUS 1 0.0000
482 HOSPITALISATION 2 0.0000
483 DECREASED APPETITE 3 0.0000
484 TREMOR 2 0.0000
485 PYREXIA 4 0.0000
486 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
487 PAIN 7 0.0000
488 ADVERSE DRUG REACTION 1 0.0000
489 NASOPHARYNGITIS 2 0.0000
490 DIARRHOEA 7 0.0000
491 OROPHARYNGEAL PAIN 1 0.0000
492 BREAST CANCER 1 0.0000
493 COUGH 3 0.0000
494 ASTHENIA 4 0.0000
495 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
496 ABDOMINAL PAIN UPPER 2 0.0000
497 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
498 ARTHRALGIA 4 0.0000
499 PLATELET COUNT DECREASED 1 0.0000
500 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
501 FALL 3 0.0000
502 THROMBOCYTOPENIA 1 0.0000
503 WEIGHT INCREASED 2 0.0000
504 ASTHMA 1 0.0000
505 RHEUMATOID ARTHRITIS 1 0.0000
506 DEPRESSION 2 0.0000
507 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
508 BACK PAIN 2 0.0000
509 JOINT SWELLING 1 0.0000
510 HYPERHIDROSIS 1 0.0000
511 PSORIASIS 1 0.0000
512 DEHYDRATION 1 0.0000
513 DRY SKIN 1 0.0000
514 PRODUCT QUALITY ISSUE 1 0.0000
515 WEIGHT DECREASED 2 0.0000
516 BLOOD PRESSURE INCREASED 1 0.0000
517 CONFUSIONAL STATE 1 0.0000
518 CEREBROVASCULAR ACCIDENT 1 0.0000
519 MYALGIA 1 0.0000
520 URINARY TRACT INFECTION 1 0.0000
521 COVID-19 1 0.0000
522 CHEST PAIN 1 0.0000
523 ANXIETY 1 0.0000
524 DEATH 1 0.0000